These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30142312)

  • 41. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
    Moser HW
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
    [No Abstract]   [Full Text] [Related]  

  • 42. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment.
    Yin Y; Fu C; Li M; Li X; Wang M; He L; Zhang LM; Peng Y
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():159-169. PubMed ID: 27287110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lorenzo's oil therapy of adrenoleukodystrophy.
    DiGregorio VY; Schroeder DJ
    Ann Pharmacother; 1995 Mar; 29(3):312-3. PubMed ID: 7606079
    [No Abstract]   [Full Text] [Related]  

  • 44. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
    Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
    J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normal natural killer cell activity in a patient with adrenoleukodystrophy treated with Lorenzo's oil.
    Tanaka M; Koike R; Kuwabara T
    Neurodegeneration; 1996 Jun; 5(2):192-4. PubMed ID: 8819141
    [No Abstract]   [Full Text] [Related]  

  • 46. Lorenzo's oil and lymphocytopenia.
    Unkrig CJ; Schröder R; Scharf RE
    N Engl J Med; 1994 Feb; 330(8):577. PubMed ID: 8204158
    [No Abstract]   [Full Text] [Related]  

  • 47. Lorenzo's oil--hope and disappointment.
    Rizzo WB
    N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
    [No Abstract]   [Full Text] [Related]  

  • 48. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy].
    Söderfeldt B
    Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039
    [No Abstract]   [Full Text] [Related]  

  • 49. Ursolic acid prevents doxorubicin-induced cardiac toxicity in mice through eNOS activation and inhibition of eNOS uncoupling.
    Mu H; Liu H; Zhang J; Huang J; Zhu C; Lu Y; Shi Y; Wang Y
    J Cell Mol Med; 2019 Mar; 23(3):2174-2183. PubMed ID: 30609217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
    Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
    Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functionalized cell nucleus-penetrating peptide combined with doxorubicin for synergistic treatment of glioma.
    Zhang L; Zhang Y; Tai L; Jiang K; Xie C; Li Z; Lin YZ; Wei G; Lu W; Pan W
    Acta Biomater; 2016 Sep; 42():90-101. PubMed ID: 27370905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling.
    Verheijen M; Schrooders Y; Gmuender H; Nudischer R; Clayton O; Hynes J; Niederer S; Cordes H; Kuepfer L; Kleinjans J; Caiment F
    Toxicol Lett; 2018 Sep; 294():184-192. PubMed ID: 29803840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early dietary treatments with Lorenzo's oil and docosahexaenoic acid for neurological development in a case with Zellweger syndrome.
    Tanaka K; Shimizu T; Ohtsuka Y; Yamashiro Y; Oshida K
    Brain Dev; 2007 Oct; 29(9):586-9. PubMed ID: 17418516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro.
    Jeong YI; Jin SG; Kim IY; Pei J; Wen M; Jung TY; Moon KS; Jung S
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):149-55. PubMed ID: 20427160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles.
    Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C
    Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombocytopenia associated with use of Lorenzo's oil.
    Chai BC; Siminoski K
    Am J Hematol; 1993 Dec; 44(4):290-1. PubMed ID: 8238006
    [No Abstract]   [Full Text] [Related]  

  • 58. Improved antitumor activity and reduced myocardial toxicity of doxorubicin encapsulated in MPEG-PCL nanoparticles.
    Sun C; Zhou L; Gou M; Shi S; Li T; Lang J
    Oncol Rep; 2016 Jun; 35(6):3600-6. PubMed ID: 27109195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of doxorubicin and 4'-epi-doxorubicin on lipid peroxidation in mouse heart, lungs and liver. Part II.
    Pierściński G; Drzewoski J; Nowak D
    Pol J Pharmacol; 1994; 46(1-2):55-9. PubMed ID: 7981772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
    Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
    Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.